Abuse of guaifenesin-containing medications generates an excess of a carboxylate salt of beta-(2-methoxyphenoxy)-lactic acid, a guaifenesin metabolite, and results in urolithiasis-Reference-Cited by-同舟云学术

Abuse of guaifenesin-containing medications generates an excess of a carboxylate salt of beta-(2-methoxyphenoxy)-lactic acid, a guaifenesin metabolite, and results in urolithiasis

Published:1999-07 Issue:1 Volume:54 Page:23-27
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Pickens Cynthia L,Milliron Abby R,Fussner Alice L,Dversdall Bart C,Langenstroer Peter,Ferguson Scott,Fu Xiong,Schmitz Francis J,Poole Edward C

Publisher

Elsevier BV

Subject

Urology

Reference14 articles.

1. Rodman J, Seidman C, and Jones R: No More Kidney Stones. New York, John Wiley & Sons, 1996, pp 5 and 20.

2. Urolithiasis associated with the protease inhibitor indinavir;Bruce;Urology,1997

3. Newer anticonvulsant drugs;Natsch;Drug Saf,1997

4. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis;Jones;Can Med Assoc J,1996

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse;Journal of Clinical Psychopharmacology;2024-01-15

2. Guaifenesin;Encyclopedia of Toxicology;2024

3. Over-the-Counter Sinonasal Medicines and Potential for Misuse;Handbook of Substance Misuse and Addictions;2022

4. Over-the-Counter Sinonasal Medicines and Potential for Misuse;Handbook of Substance Misuse and Addictions;2022

5. Drug-Induced Nephrolithiasis;Diagnosis and Management of Pediatric Nephrolithiasis;2022